APOE and Alzheimer disease: Although the mechanism of how APOE modifies AD risk is not completely understood, an additional copy of APOE ε4 is more likely to promote Aβ aggregation and is thought to increase the stability of Aβ oligomers when compared to APOE ε2 or APOE ε3 [52, 116–119].